Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin conditioning of cadaveric organ donors after brain death
2009-013398-16Phase 2Active
- Sponsor
- Rafael Selgas
- Start
- Aug 2009
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of antithymocyte globulin in acute rejection (AR) and delayed graft function (DGF), sponsored by Rafael Selgas. Primary endpoint: Change in inflammatory marker expression in graft biopsies. Started Aug 2009; status: active.
02
Drugs
antithymocyte globulin
03
Conditions
acute rejection (AR)delayed graft function (DGF)
Beyond the preview
Go deeper on 2009-013398-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013398-16.